Immunome Set to Acquire Atreca’s Antibody-Related Assets in a Move to Revolutionize Cancer Therapies
EXTON, PA — Immunome, Inc. (Nasdaq: IMNM), a leading biotech firm specializing in cancer therapies, recently announced its plan to purchase a trove of antibody-related assets from Atreca, Inc. (Nasdaq: …
Immunome Set to Acquire Atreca’s Antibody-Related Assets in a Move to Revolutionize Cancer Therapies Read More